Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300/anti-silencing function 1B histone chaperone/PI3K/AKT/mTOR axis

被引:38
作者
Wang, Leiming [1 ]
Yang, Xi [1 ]
Zhou, Fei [1 ]
Sun, Xuesi [1 ]
Li, Shulin [1 ]
机构
[1] Xuzhou Med Univ, Affiliated Shuyang Hosp, Dept Gen Surg, 9 Yingbin Rd, Suqian City 223600, Jiangsu, Peoples R China
关键词
CircUBAP2; cisplatin; TNBC; ceRNA; PI3K; AKT; mTOR signaling; SQUAMOUS-CELL CARCINOMA; ACTIVATING PI3K/AKT/MTOR; PROMOTES; METASTASIS; PROLIFERATION; PROGRESSION;
D O I
10.1080/21655979.2022.2036894
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Circular RNAs (CircRNAs) have attracted increasing attention in the diagnosis and treatment of human cancers. CircUBAP2 has been identified to promote the progression of triple-negative breast cancer (TNBC), but the function of circUBAP2 in the cisplatin (DDP) resistance of TNBC remains obscure. Our investigation showed that circUBAP2 was significantly upregulated in DDP-resistant TNBC and TNBC sensitivity to DDP could be enhanced by silencing of circUBAP2. Moreover, circUBAP2 was revealed to be a ceRNA for miR-300 to upregulate the expression of anti-silencing function 1B histone chaperone (ASF1B). The effect of circUBAP2/miR-300/ASF1B axis on DDP resistance of TNBC was evaluated by rescue experiments, which demonstrated that circUBAP2 inhibited TNBC sensitivity to DDP through miR-300/ASF1B axis. Furthermore, it was discovered that ASF1B activated PI3K/AKT/mTOR signaling to facilitate the DDP resistance of TNBC cells. In summary, this research revealed a novel regulatory mechanism that circUBAP2 functioned as ceRNA of miR-300 to upregulate ASF1B, which further triggered the PI3K/AKT/mTOR (PAM) signaling to enhance the DDP resistance of TNBC.
引用
收藏
页码:7197 / 7208
页数:12
相关论文
共 51 条
[1]   Upregulation of microRNA-300 induces the proliferation of liver cancer by downregulating transcription factor FOXO1 [J].
Chang, Yuanhong ;
Zhou, Cancan ;
Fan, Lin ;
Qiu, Guanglin ;
Wang, Guanghui ;
Wei, Guangbing ;
Chang, Xinming ;
Li, Xuqi .
ONCOLOGY REPORTS, 2018, 40 (06) :3561-3572
[2]   Circular RNA ubiquitin-associated protein 2 enhances autophagy and promotes colorectal cancer progression and metastasis via miR-582-5p/FOXO1 signaling [J].
Chen, Feifei ;
Guo, Lei ;
Di, Jiehui ;
Li, Man ;
Dong, Dong ;
Pei, Dongsheng .
JOURNAL OF GENETICS AND GENOMICS, 2021, 48 (12) :1091-1103
[3]   Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy [J].
Corbeau, Ileana ;
Thezenas, Simon ;
Maran-Gonzalez, Aurelie ;
Colombo, Pierre-Emmanuel ;
Jacot, William ;
Guiu, Severine .
CANCERS, 2020, 12 (09) :1-16
[4]   Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer [J].
Corpet, Armelle ;
De Koning, Leanne ;
Toedling, Joern ;
Savignoni, Alexia ;
Berger, Frederique ;
Lemaitre, Charlene ;
O'Sullivan, Roderick J. ;
Karlseder, Jan ;
Barillot, Emmanuel ;
Asselain, Bernard ;
Sastre-Garau, Xavier ;
Almouzni, Genevieve .
EMBO JOURNAL, 2011, 30 (03) :480-493
[5]   Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review [J].
Costa, Ricardo L. B. ;
Han, Hyo Sook ;
Gradishar, William J. .
BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (03) :397-406
[6]   CircRNA UBAP2 facilitates the progression of colorectal cancer by regulating miR-199a/VEGFA pathway [J].
Dai, J. ;
Zhuang, Y. ;
Tang, M. ;
Qian, Q. ;
Chen, J-P .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (15) :7963-7971
[7]   Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance [J].
Ediriweera, Meran Keshawa ;
Tennekoon, Kamani Hemamala ;
Samarakoon, Sameera Ranganath .
SEMINARS IN CANCER BIOLOGY, 2019, 59 :147-160
[8]   Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway [J].
Fan, Shaoxia ;
Yan, Shen ;
Yang, Yang ;
Shang, Jian ;
Hao, Min .
ONCOTARGETS AND THERAPY, 2021, 14 :2463-2473
[9]  
Ge WS, 2016, AM J TRANSL RES, V8, P3903
[10]   CircRNA_102272 Promotes Cisplatin-Resistance in Hepatocellular Carcinoma by Decreasing MiR-326 Targeting of RUNX2 [J].
Guan, Yonghai ;
Zhang, Ying ;
Hao, Lina ;
Nie, Zhenwang .
CANCER MANAGEMENT AND RESEARCH, 2020, 12 :12527-12534